Webster, E. M., Zeybek, B., Tymon-Rosario, J., & Santin, A. D. (2020). Sacituzumab govitecan: A promising antibody-drug conjugate for the treatment of poorly differentiated endometrial cancer. Oncoscience.
Chicago Style CitationWebster, Emily M., Burak Zeybek, Joan Tymon-Rosario, i Alessandro D. Santin. "Sacituzumab Govitecan: A Promising Antibody-drug Conjugate for the Treatment of Poorly Differentiated Endometrial Cancer." Oncoscience 2020.
Cita MLAWebster, Emily M., Burak Zeybek, Joan Tymon-Rosario, i Alessandro D. Santin. "Sacituzumab Govitecan: A Promising Antibody-drug Conjugate for the Treatment of Poorly Differentiated Endometrial Cancer." Oncoscience 2020.
Atenció: Aquestes cites poden no estar 100% correctes.